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Abstract
Background: The aim of this study was to develop a simple organ score derived from the Critical
Care Minimum Data Set (CCMDS) to compare with the Sequential Organ Failure Assessment
(SOFA) score, a previously validated score of organ dysfunction.
Findings: The CCMDS collects data regarding the support of seven organ systems. To create a
CCMDS derived score each level of organ support was allocated a numerical value. SOFA scores
were collected retrospectively from each patient in the study. Data was collected in 50 sequential
admissions over the first 5 days of their admission. This generated a total of 147 pairs of data for
comparison.
Scatter plots and Spearman's rank correlation coefficient suggest a weak positive association
between our CCMDS-derived score and the SOFA score. Daily Bland-Altman plots reveal minimal
bias between the score but wide limits of agreement.
Conclusion: Our CCMDS-derived score cannot be regarded as an indicator of severity of organ
dysfunction and cannot replace SOFA scores when a daily marker of organ dysfunction is required.
Findings
The Critical Care Minimum Data Set (CCMDS) was intro-
duced in April 2006 and collates data daily regarding all
patients, excluding neonates, in level 2 or 3 critical care
beds in England and Wales. The CCMDS was developed
by the Critical Care Information Advisory Group and is
endorsed by the Intensive Care Society. The data consists
of 34 fields which allow calculation of admission dura-
tion, basic demographic information, level of care and
category of intensive care unit (general, neurosurgical, car-
diothoracic etc). Information is also collected regarding
the number of organs supported and, in the case of the
cardiovascular and respiratory systems, the level of sup-
port. Data is currently submitted to the Intensive Care
National Audit and Research Centre (ICNARC) as part of
the Case Mix Programme. During 2008 data collection
became mandatory and will be used to calculate a pay-
ment tariff under the Payment by Results (PbR) scheme
within all NHS hospitals.
Our aim was to develop a simple organ score derived from
the CCMDS to compare with a previously validated score
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of organ dysfunction. The Sequential Organ Failure
Assessment (SOFA) score is a very commonly used scoring
system designed to follow morbidity of critically ill
patients[1]. It records severity of dysfunction of six organ
systems. Improvement in organ dysfunction scores, such
as SOFA, monitor improvements in a patient's condition
following an intervention or as an end point for clinical
trials. More recently, organ dysfunction scores have been
validated, not only as an initial indicator of outcome on
admission to ICU, but also as a predictor of mortality,
dependant on changes in daily scores during a patient's
ICU admission [2-4]. Organ dysfunction scores are time
consuming and expensive to collect, requiring additional
clerical support so a CCMDS-derived score could repre-
sent a saving of both time and money to UK intensive care
units especially those involved in clinical trials.
The CCMDS collects data regarding the support of seven
organ systems. The support of the cardiovascular and res-
piratory systems is further divided into basic and
advanced support, whilst the other five systems are either
supported or not. Table 1 defines each method of organ
support [5]. SOFA scores were collected retrospectively
from each patient in the study. The study ICU routinely
documents Bloomsbury sedation scores rather than Glas-
gow Coma Scores (GCS) as recorded in the SOFA score[6].
Table 2 illustrates the scheme used to convert the sedation
score to the neurological component of the SOFA score. In
order to create a CCMDS derived score each level of organ
support was allocated a numerical value (Table 3) with
basic support scoring 1 and advanced support scoring 2.
We did not allocate a particular weighting to any of the
scores.
Table 1: Summary of definitions of levels of organ support in the critical care minimum data set [5].
Organ system Definition of level of support
Basic respiratory • > 50% oxygen delivered by face mask
￿ Close observation due to the potential for acute deterioration
￿ Physiotherapy or suction to clear secretions at least two hourly
￿ Patients recently extubated after a prolonged period of intubation and mechanical ventilation
￿ Mask CPAP or non-invasive ventilation.
￿ Patients who are intubated to protect the airway but needing no ventilatory support and who are otherwise stable
Advanced respiratory ￿ Invasive mechanical ventilatory support
￿ Extracorporeal respiratory support
Basic cardiovascular ￿ Treatment of circulatory instability due to hypovolaemia
￿ Use of a CVP line for basic monitoring or central access
￿ Use of an arterial line for basic monitoring or sampling
￿ Single intravenous vasoactive
￿ Intravenous drugs to control cardiac arrhythmias
￿ Non-invasive measurement of cardiac
Advanced cardiovascular ￿ Multiple intravenous vasoactive and/or rhythm controlling drugs
￿ Patients resuscitated after cardiac arrest where intensive therapy is considered clinically appropriate.
￿ Observation of cardiac output and derived
￿ Intra aortic balloon pumping.
￿ Temporary cardiac
￿ Placement of a gastrointestinal tonometer
Renal ￿ Acute renal replacement therapy
Neurological ￿ Central nervous system depression sufficient to prejudice the airway and protective reflexes
￿ Invasive neurological monitoring
￿ Severely agitated or epileptic patients requiring constant nursing attention and/or heavy sedation
Gastrointestinal ￿ Feeding with parenteral or enteral nutrition
Dermatological ￿ Patients with major skin rashes, exfoliation or burns
￿ Use of multiple, large trauma dressings
￿ Use of complex dressings
Liver ￿ Extracorporeal liver replacement deviceBMC Research Notes 2009, 2:77 http://www.biomedcentral.com/1756-0500/2/77
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Our aim was to retrospectively collect SOFA scores and the
CCMDS-derived score on fifty admissions to a teaching
hospital general intensive care unit from January 1st 2007.
The local ethics committee was informed and indicated
that no formal approval of this retrospective study was
required. Data was collected from day 0 to day 5 of each
patient's admission. Seven of the original fifty patients
had insufficient data to allow calculation of either a SOFA
score or CCMDS derived score. In total 147 pairs of data,
both SOFA and CCMDS-derived scores were collected
with each patient contributing between two and six data
points. Data was initially analysed for correlation and
agreement by plotting a scatter plot of the scores of one
method against those of the other for each day of admis-
sion. Subsequently a Spearman's rank test and a Bland
and Altman plot were performed on data collected for
each day to assess whether these two methods can be used
interchangeably[7].
Visual inspection of the graphs comparing the CCMDS-
derived score and SOFA score suggests a weak positive
association. The graphs for day 0 and day 1 are illustrated
in figure 1 and 2. The weak positive correlation is con-
firmed using Spearman's rank test, applied to data col-
lected on each day. This gives a correlation coefficient
between r = 0.350 to r = 0.609 with the p value for each
day (shown in table 4), suggesting a significant correla-
tion (range of p values p = 0.002 to p = 0.047), with the
exception of day 2 (p = 0.054). This would suggest that the
ranking of patients from high to low risk is similar for
both scores.
Levels of agreement were checked using a Bland and Alt-
man plot for each day of data collected. As the total score
for both score was not identical a percentage change in the
score was used. An example of the Bland and Altman plot
is shown in figure 3 comparing the changes in scores
between day 0 and day 1. Both scores were expressed as a
percentage change from the baseline admission score.
There is a broad spread of results in the graphs produced
for each day of data collected, reflecting a poor level of
agreement. The average overall bias between the two
scores, in the percentage change from baseline was mini-
mal on day 1 to 0 i.e. 1%. However the 95% limits of
agreement were -84% to 86%. This wide margin of disa-
greement could be expected as the SOFA score has a much
greater range than the CCMDS-derived score. It is there-
fore likely to be a more sensitive measure of change. Sim-
ilar results were obtained for data on all the other days.
The limits of agreement for each day as a percentage
change from baseline are shown in table 5.
The aim of our CCMDS-derived score was to produce a
simple, daily scoring system that would monitor severity
of organ dysfunction but require no additional adminis-
trative input and therefore no additional cost implica-
tions. The results show a statistical correlation between
the CCMDS-derived score and SOFA score as indicators of
organ dysfunction, confirming the ranking of patients is
similar for the two scoring systems. The r2 values suggest
that factors not included in the SOFA score affect our
CCMDS-derived score. However, the Bland and Altman
plots display a poor degree of agreement between the two
scores but with minimal overall bias.
Based on this pilot data from 43 patients our CCMDS-
derived score cannot be regarded as an indicator of the
severity of organ dysfunction when compared with the
SOFA score. It is our view, at present in critically ill
patients, an organ dysfunction score derived form the
Table 2: System used for conversion from sedation score to neurological component of the SOFA score.
Sedation score Neurological component
of SOFA score
Agitated/restless 3 1 (GCS 13–14)
Awake/uncomfortable 2 1 (GCS 13–14)
Awake/calm 1 0 (GCS 15)
Roused by voice 0 2 (GCS 10–12)
Roused by movement -1 3 (GCS 6–9)
Rouse by pain -2 3 (GCS 6–9)
Unrousable -3 4 (GCS < 6)
Paralysed P4  ( G C S  <  6 )BMC Research Notes 2009, 2:77 http://www.biomedcentral.com/1756-0500/2/77
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CCMDS cannot replace the SOFA score in studies where a
daily indicator of the severity of organ dysfunction is
required. This may be explained by the different purpose
of each score. The SOFA score was developed and vali-
dated as a tool to quantify organ dysfunction. In contrast,
the CCMDS was developed to calculate the level of
dependency of a patient as a way of calculating remuner-
ation for critical care units. Whilst the level of organ dys-
function is related to the dependency of the patient the
two scores quantify two distinct entities.
The sample size was set at 50 as this was a pilot study to
determine the feasibility of using a CCMDS-derived score
as an organ dysfunction score. Although a larger sample
size may reduce the chance of a negative result being a
type II error we feel that this is unlikely in view of the con-
sistency of the results. The small sample size and original
premise of this pilot study makes more detailed statistical
analysis beyond the remit of this study. This does, how-
ever, limit the conclusions that can be drawn from the
data. Based on the results of this study it is unlikely that a
large prospective study with detailed statistical analysis
would produce a satisfactory new organ dysfunction score
based on the CCMDS. Specific weaknesses of the study are
the derived neurological component of the SOFA score, its
retrospective nature and small sample size. The Glasgow
Coma Score is not routinely collected in the study inten-
sive care unit thereby necessitating a conversion of seda-
tion scores to GCS. A prospective study would be able to
record GCS. However this would defeat the main inten-
Table 3: The CCMDS-derived score
Score
Respiratory support No support 0
Basic support 1
Advance support 2
Cardiovascular support No support 0
Basic support 1
Advance support 2
Renal support No support 0
Support 1
Neurological support No support 0
Support 1
GI support No support 0
Support 1
Dermatological support No support 0
Support 1
Liver support No support 0
Support 1
Comparison of CCMDS-derived score and the SOFA score  on day 0 Figure 1
Comparison of CCMDS-derived score and the SOFA 
score on day 0. Figure 1 shows a XY scatter plot comparing 
the CCMDS derived score with the SOFA score on day 0.
Comparison of CCMDS-derived score and the SOFA score  on day 1 Figure 2
Comparison of CCMDS-derived score and the SOFA 
score on day 1. Figure 2 shows a XY scatter plot comparing 
the CCMDS derived score with the SOFA score on day 1.BMC Research Notes 2009, 2:77 http://www.biomedcentral.com/1756-0500/2/77
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tion of the study to record a score that requires no addi-
tional administrative costs. This study is to our
knowledge, the first attempt to use the critical care mini-
mum data set to predict organ dysfunction.
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Table 4: Spearman's rank correlation coefficient for the CCMDS-
derived score compared to SOFA scores for day 0 to day 5.
Day Correlation coefficient (r value) r2 p value
0 0.350 0.123 0.046
1 0.516 0.266 0.002
2 0.398 0.158 0.054
3 0.536 0.287 0.015
4 0.529 0.280 0.035
5 0.609 0.371 0.047
Bland and Altman plot comparing the CCMDS-derived score  and SOFA day 0 to day 1 Figure 3
Bland and Altman plot comparing the CCMDS-
derived score and SOFA day 0 to day 1. Figure 3 shows 
a Bland and Altman plot comparing the difference in percent-
age change, from day 0 to day 1, in the CCMDS-derived 
score and SOFA score with the average of the CCMDS-
derived score and SOFA score. the limits of agreement are 
indicated by the red lines.
Table 5: Levels of agreement derived from the Bland and 
Altman plots for the 5 days of admission.
Bias Limits of Agreement
Day 0 to 1 1% -84% to 86%
Day 0 to 2 4% -58% to 65%
Day 0 to 3 7% -49% to 63%
Day 0 to 4 9% -59% to 78%
Day 0 to 5 11% -50% to 72%